Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bjoern Moosmann

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Drug Testing and Analysis|April 6, 2017
Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepineLaura M Huppertz, Bjoern Moosmann, Volker Auwärter
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 5, 2015
Designer benzodiazepines: A new challengeBjoern Moosmann, Leslie A King, Volker Auwärter
Drug Testing and Analysis|August 10, 2016
Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samplesFlorian Franz, Verena Angerer, Bjoern Moosmann, et al.
Drug Testing and Analysis|May 25, 2013
Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperaturesStefan Kneisel, Michael Speck, Bjoern Moosmann, et al.
Journal of Mass Spectrometry : JMS|July 9, 2013
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolismMelanie Hutter, Bjoern Moosmann, Stefan Kneisel, et al.
Forensic Science International|June 15, 2016
Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopyVerena Angerer, Philippe Bisel, Bjoern Moosmann, et al.
Journal of Analytical Toxicology|January 30, 2016
Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'Verena Angerer, Florian Franz, Bernd Schwarze, et al.
Analytical and Bioanalytical Chemistry|October 16, 2012
A fast and inexpensive procedure for the isolation of synthetic cannabinoids from 'Spice' products using a flash chromatography systemBjoern Moosmann, Stefan Kneisel, Ariane Wohlfarth, et al.
Forensic Toxicology|January 15, 2019
5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACAVerena Angerer, Florian Franz, Bjoern Moosmann, et al.
Analytical and Bioanalytical Chemistry|March 4, 2016
Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?Florian Franz, Verena Angerer, Maren Hermanns-Clausen, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Drug Testing and Analysis|April 6, 2017
Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepineLaura M Huppertz, Bjoern Moosmann, Volker Auwärter
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|June 5, 2015
Designer benzodiazepines: A new challengeBjoern Moosmann, Leslie A King, Volker Auwärter
Drug Testing and Analysis|August 10, 2016
Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samplesFlorian Franz, Verena Angerer, Bjoern Moosmann, et al.
Drug Testing and Analysis|May 25, 2013
Stability of 11 prevalent synthetic cannabinoids in authentic neat oral fluid samples: glass versus polypropylene containers at different temperaturesStefan Kneisel, Michael Speck, Bjoern Moosmann, et al.
Journal of Mass Spectrometry : JMS|July 9, 2013
Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolismMelanie Hutter, Bjoern Moosmann, Stefan Kneisel, et al.
Forensic Science International|June 15, 2016
Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopyVerena Angerer, Philippe Bisel, Bjoern Moosmann, et al.
Journal of Analytical Toxicology|January 30, 2016
Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'Verena Angerer, Florian Franz, Bernd Schwarze, et al.
Analytical and Bioanalytical Chemistry|October 16, 2012
A fast and inexpensive procedure for the isolation of synthetic cannabinoids from 'Spice' products using a flash chromatography systemBjoern Moosmann, Stefan Kneisel, Ariane Wohlfarth, et al.
Forensic Toxicology|January 15, 2019
5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACAVerena Angerer, Florian Franz, Bjoern Moosmann, et al.
Analytical and Bioanalytical Chemistry|March 4, 2016
Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?Florian Franz, Verena Angerer, Maren Hermanns-Clausen, et al.
Pageof 4